Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 1
1990 1
1991 2
1995 1
1997 1
2003 3
2004 2
2005 1
2006 3
2007 1
2008 1
2009 1
2013 1
2014 2
2016 1
2017 2
2018 1
2019 2
2020 1601
2021 709
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

2,109 results
Use COVID-19 filters from PubMed Clinical Queries to refine your search See more SARS-CoV-2 literature, sequence, and clinical content from NCBI
Results by year
Filters applied: . Clear all
Page 1
Chloroquine for the 2019 novel coronavirus SARS-CoV-2.
Colson P, Rolain JM, Raoult D. Colson P, et al. Int J Antimicrob Agents. 2020 Mar;55(3):105923. doi: 10.1016/j.ijantimicag.2020.105923. Epub 2020 Feb 15. Int J Antimicrob Agents. 2020. PMID: 32070753 Free PMC article. No abstract available.
Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
Gao J, Hu S. Gao J, et al. Biosci Trends. 2020 May 21;14(2):156-158. doi: 10.5582/bst.2020.03072. Epub 2020 Apr 13. Biosci Trends. 2020. PMID: 32281583 Free article.
Drugs that are specifically efficacious against SARS-CoV-2 have yet to be established. Chloroquine and hydroxychloroquine have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Increasing evidence obtained from complet …
Drugs that are specifically efficacious against SARS-CoV-2 have yet to be established. Chloroquine and hydroxychloroquine have garner …
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Devaux CA, Rolain JM, Colson P, Raoult D. Devaux CA, et al. Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12. Int J Antimicrob Agents. 2020. PMID: 32171740 Free PMC article.
Recently, a novel coronavirus (2019-nCoV), officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. ...In the absence of a known efficient therapy and because of the situation of a public-health emergency, it made sense to …
Recently, a novel coronavirus (2019-nCoV), officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), e …
Of chloroquine and COVID-19.
Touret F, de Lamballerie X. Touret F, et al. Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5. Antiviral Res. 2020. PMID: 32147496 Free PMC article. Review.
Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in lig …
Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment …
Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
Ibáñez S, Martínez O, Valenzuela F, Silva F, Valenzuela O. Ibáñez S, et al. Clin Rheumatol. 2020 Aug;39(8):2461-2465. doi: 10.1007/s10067-020-05202-4. Epub 2020 Jun 3. Clin Rheumatol. 2020. PMID: 32495226 Free PMC article. Review.
The pandemic of the new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has urged the nations to an unprecedented world-wide reaction, including an accelerated exploration of therapeutic options. In the absence of a vaccine and sp …
The pandemic of the new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has urged the nati …
Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review.
Pereira BB. Pereira BB. J Toxicol Environ Health B Crit Rev. 2020 May 18;23(4):177-181. doi: 10.1080/10937404.2020.1752340. Epub 2020 Apr 12. J Toxicol Environ Health B Crit Rev. 2020. PMID: 32281481 Free PMC article. Review.
As a result of the 2019 coronavirus disease pandemic (COVID-19), there has been an urgent worldwide demand for treatments. Due to factors such as history of prescription for other infectious diseases, availability, and relatively low cost, the use of chloroquine (CQ …
As a result of the 2019 coronavirus disease pandemic (COVID-19), there has been an urgent worldwide demand for treatments. Due to fac …
A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
Shah S, Das S, Jain A, Misra DP, Negi VS. Shah S, et al. Int J Rheum Dis. 2020 May;23(5):613-619. doi: 10.1111/1756-185X.13842. Epub 2020 Apr 27. Int J Rheum Dis. 2020. PMID: 32281213 Free PMC article.
OBJECTIVE: The pandemic coronavirus disease-19 (COVID-19) has pushed the global healthcare system to a crisis and amounted to a huge economic burden. Different drugs for prophylaxis against COVID-19 including chloroquine (CQ) or hydroxychloroquine (HCQ) have been tr …
OBJECTIVE: The pandemic coronavirus disease-19 (COVID-19) has pushed the global healthcare system to a crisis and amounted to a huge …
2,109 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page